PDS Biotechnology Corporation
PDSB
$1.10
-$0.20-15.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -36.33% | 4.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.00% | 6.78% | |||
| Operating Income | 18.00% | -6.78% | |||
| Income Before Tax | 16.06% | 4.50% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 16.06% | 4.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 16.06% | 4.50% | |||
| EBIT | 18.00% | -6.78% | |||
| EBITDA | 18.04% | -6.79% | |||
| EPS Basic | 23.73% | 6.47% | |||
| Normalized Basic EPS | 23.73% | 6.54% | |||
| EPS Diluted | 23.73% | 6.47% | |||
| Normalized Diluted EPS | 23.73% | 6.54% | |||
| Average Basic Shares Outstanding | 10.07% | 2.11% | |||
| Average Diluted Shares Outstanding | 10.07% | 2.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||